← FDA Drug Approvals (Drugs@FDA)
TRETINOIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALLERGAN · Approved 2012-10-11
Drug application
- FDA Application #
ANDA202209- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TRETINOIN
- Generic name
- Tretinoin
- Active ingredients
- TRETINOIN
- Dosage form
- CREAM
- Route
- TOPICAL
- Marketing status
- Discontinued
- Sponsor
- ALLERGAN
- First approval
- 2012-10-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown